Search results for “Myelodysplastic syndromes” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,588 patents, we discovered top 239 key players by total patent application. Celgene Corp., Novartis AG, Boehringer Ingelheim International GmbH are dominant in this area. They take 24.50% of the total patent filing.
New Jersey, United States
Patent: 176
Basel-Stadt, Switzerland
Patent: 138
Rheinland-Pfalz, Germany
Patent: 75
Antwerpen, Belgium
Patent: 68
California, United States
Patent: 47
United States
Patent: 45
California, United States
Patent: 38
Massachusetts, United States
Patent: 36
Indiana, United States
Patent: 32
California, United States
Patent: 31
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 43 patents, we discovered top 11 start-ups by total patent application. Forty Seven, Inc., Starton Therapeutics, Inc., ALX Oncology, Inc. are active in this area.
STARTUP
California, United States
Patent: 12
STARTUP
New York, United States
Patent: 7
STARTUP
California, United States
Patent: 5
STARTUP
United States
Patent: 4
STARTUP
Kurome Therapeutics, Inc.
Ohio, United States
Patent: 4
STARTUP
Massachusetts, United States
Patent: 3
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
Massachusetts, United States
Patent: 1
STARTUP
Noord-Holland, Netherlands
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 595 patents applied in the last 5 years. We discover 144 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, MacroGenics, Inc., Celgene Corp. take 19.83% of patent filing during this period.
Antwerpen, Belgium
Patent: 45
United States
Patent: 43
New Jersey, United States
Patent: 30
California, United States
Patent: 30
Basel-Stadt, Switzerland
Patent: 29
Alabama, United States
Patent: 28
NOTTINGHAM, United Kingdom
Patent: 19
United States
Patent: 15
Berlin, Germany
Patent: 15
Massachusetts, United States
Patent: 13
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 595 patents in last 5 years, we discover 83 new entrants. Nottingham Trent University, Silence Therapeutics GmbH, Forty Seven, Inc. are the most active new entrants in this area.
NOTTINGHAM, United Kingdom
Patent: 19
Berlin, Germany
Patent: 15
STARTUP
California, United States
Patent: 12
Washington, United States
Patent: 11
Washington, United States
Patent: 11
Tokyo-to, Japan
Patent: 8
Pinotbio
undefined undefined
Patent: 8
Shanghai Shi, China
Patent: 8
Minnesota, United States
Patent: 8
New York, United States
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 367 patents, we discovered top 47 universities and scientific research institutions by total patent application. Nottingham Trent University, University of Bern, Friedrich-Alexander-Universität Erlangen-Nürnberg are dominant in this area. They take 23.98% of the total patent filing.
NOTTINGHAM, United Kingdom
Patent: 19
Bern, Switzerland
Patent: 14
Bayern, Germany
Patent: 13
New York, United States
Patent: 9
France
Patent: 8
New York, United States
Patent: 7
Tokyo-to, Japan
Patent: 7
Tokyo-to, Japan
Patent: 7
Vlaams-Brabant, Belgium
Patent: 7
New York, United States
Patent: 6
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: